SHE:301281 Revenue

Shandong Keyuan Pharmaceutical had revenue of 74.82M CNY in the quarter ending September 30, 2025, a decrease of -20.18%. This brings the company's revenue in the last twelve months to 435.52M, down -0.52% year-over-year. In the year 2024, Shandong Keyuan Pharmaceutical had annual revenue of 463.72M with 3.60% growth.

Revenue (ttm)

435.52M

Revenue Growth

-0.52%

P/S Ratio

10.43

Revenue / Employee

625.75K

Employees

696

Market Cap

4.54B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	463.72M	16.13M	3.60%
Dec 31, 2023	447.58M	4.72M	1.07%
Jan 1, 2023	442.87M	21.98M	5.22%
Jan 1, 2022	420.89M	53.83M	14.67%
Dec 31, 2020	367.06M	56.05M	18.02%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Hangzhou Bio-Sincerity Pharma-Tech	590.33M
Hangzhou Minsheng Healthcare	744.06M
Chongqing Lummy Pharmaceutical	771.02M
Hunan Jingfeng Pharmaceutical	393.19M
Guangdong Jiaying Pharmaceutical	410.00M
Zhejiang Haisen Pharmaceutical	510.33M
Zhejiang Int'l Group	33.54B
Shanghai Shenqi Pharmaceutical Investment Management	1.88B

Revenue Rankings